Market revenue in 2023 | USD 59.3 million |
Market revenue in 2030 | USD 80.1 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services & Others |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Rapid Testing Devices, Consumables, Services & Others |
Key market players worldwide | Abbott Laboratories, Quest Diagnostics Inc, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Labcorp Holdings Inc, OraSure Technologies Inc, Omega Laboratories, Draegerwerk AG & Co KGaA, Bio-Rad Laboratories Inc Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug screening market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 43% in 2023. Horizon Databook has segmented the UAE drug screening market based on instruments, rapid testing devices, consumables, services & others covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE drug screening market , including forecasts for subscribers. This country databook contains high-level insights into UAE drug screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account